[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"biliary-fistula\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:biliary-fistula":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,46],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":29,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100563135","biliary-fistulas-in-surgery-of-liver-echinococcosis-100563135",false,"NCT06612229","Biliary Fistulas in Surgery of Liver Echinococcosis","Improvement of Methodological Approaches to Diagnostics and Tactics of Treatment of Biliary Fistulas in Surgery of Liver Echinococcosis","BFISOLE","Inclusion Criteria:\n\n* Age under 18 years;\n* Informed consent for inclusion in the study;\n* The presence of liver echinococcosis, for which conservative surgical treatment will be performed;\n* The presence of the entire spectrum of necessary preoperative diagnostic measures;\n* A full description of all stages of surgical intervention, indicating the type of intervention (open or laparoscopic surgery, location and size of the echinococcal cyst in the liver, type of antiparasitic treatment, presence or absence of a biliary fistula in the residual cavity, actions taken in relation to the fistula, the option of eliminating the residual cavity and drainage;\n* Availability of objective data on the characteristics of the postoperative course, including dynamic indicators of the patient\\'s condition, temperature, amount and nature of discharge through the drainage, the time of drainage removal, the type of complications (if any) and the method of their treatment, the duration of the hospital period, data on the characteristics of the posthospital period up to 3 months of observation;\n* Absence of concomitant pathology that may affect the outcome of the surgery.\n\nExclusion Criteria:\n\n* Age under 18 years;\n* Refusal to participate in the study;\n* Extrahepatic echinococcosis without liver damage;\n* Absence of the full range of preoperative diagnostic data;\n* Difficulties with objective analysis of the features of the performed surgical treatment;\n* Incomplete data on monitoring the postoperative hospital and remote (up to 3 months) period;\n* The presence of concomitant pathology that may affect the outcome of the operation.","ALL","18 Years",{"count":20,"type":21},200,"ESTIMATED","INTERVENTIONAL",[24],"NA","The objective of the study is to improving the results of surgical treatment of liver echinococcosis complicated by biliary fistula by optimizing diagnostic approaches to early verification of this complication and improving the tactical and technical aspects of its elimination.",[27,28],"Echinococcosis, Hepatic","Biliary Fistula",[30,31,32],"Echinococcosis of the liver","Biliary fistula","Conservative surgical treatment","RECRUITING","2025-12-29",{"date":36,"type":37},"2025-12-30","ACTUAL",{"date":39,"type":37},"2023-10-22",{"date":41,"type":21},"2026-12-23",{"name":43,"class":44},"Republican Specialized Scientific and Practical Medical Center of Surgery Named After V. Vakhidov","OTHER",1,{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":4,"eligibilityCriteria":52,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":53,"targetDuration":55,"studyType":56,"phases":4,"briefSummary":57,"conditions":58,"keywords":65,"overallStatus":68,"whyStopped":4,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":72,"completionDateStruct":73,"leadSponsor":75,"locationsCount":4},"100567619","spanish-registry-of-quality-indicators-and-adverse-events-of-endoscopic-retrograde-cholangiopancreatography-100567619","NCT06670547","Spanish Registry of Quality Indicators and Adverse Events of Endoscopic Retrograde Cholangiopancreatography","Prospective and Multicenter Spanish Registry of Quality Indicators and Adverse Events of Endoscopic Retrograde Cholangiopancreatography","Inclusion Criteria:\n\nAll consecutive patients who have undergone an ERCP at participating centres from 1 November 2024 will be included. An ERCP will be considered to have been performed when an endoscope is introduced to access the duodenal papilla.\n\nThese included patients must meet all of the following criteria:\n\n* Over 18 years of age\n* Signed informed consent.\n\nExclusion Criteria:\n\n* Under 18 years of age\n* Unavailability of informed consent\n* Impossibility of follow-up.",{"count":54,"type":21},3000,"30 Days","OBSERVATIONAL","Endoscopic retrograde cholangiopancreatography (ERCP) is a technique which combines endoscopic and radiological vision and allows for therapeutic procedures on pathologies of the pancreas and bile duct.\n\nERCP is a generally well tolerated procedure, nonetheless it is a complex technique that has a higher frequency of complications compared to most endoscopic procedures that can even be life-threatening. These complications are related to patient characteristics, experience of the endoscopist performing the procedure, and specific factors to the technique. Due to its complexity, quality assurance, operator training and auditing are required to increase success and minimize complications.\n\nThere are quality indicators suggested by the main scientific societies in relation to technical aspects and complications, recommending their monitoring and auditing. Most endoscopy units lack records to monitor quality and complications, which prevents the assessment of quality and the identification of areas for improvement.\n\nGiven the lack of evidence of the quality of ERCP in the Spanish population, the investigators will be conducting a multicenter, national prospective study that will include subjects who undergo ERCP.\n\nPatient data and technical aspects of the procedure will be recorded and all included patients will be monitored to identify complications. The quality indicators obtained within the registry will be compared with those established by scientific societies and the relationship between complications and technical factors will be analyzed.",[59,60,61,62,63,64,28],"Choledocholithiasis","Choledocholithiasis With Acute Cholangitis","Cholangiocarcinoma","Sclerosing Cholangitis","Pancreatic Cancer Resectable","Pancreatic Cancer Non-resectable",[66,67],"ERCP ADVERSE EVENTS","PERFORMANCE MEASURES","NOT_YET_RECRUITING","2024-10-31",{"date":71,"type":37},"2024-11-01",{"date":71,"type":21},{"date":74,"type":21},"2028-10-30",{"name":76,"class":44},"Germans Trias i Pujol Hospital"]